BioSpace News Archive

Drug Development

D&D Pharmatech Announces First Patient Dosed in Phase 1 Clinical Trial of DD01 in Obese Patients with Diabetes and NAFLD

DD01 is a long-acting dual agonist of GLP-1 and glucagon receptors, which resulted in weight loss, improved metabolic control and reduced fatty liver in animal models of human disease.

March 30, 2021
·
3 min read
Business

Paige Announces Appointment of Andy Moye as Chief Commercial Officer and Dr. Juan Antonio Retamero as Medical Director

Paige , a global leader in AI-based diagnostic software in pathology, today announced it has appointed Andy Moye, Ph.D. as Chief Commercial Officer and Juan Antonio Retamero, M.D. as Medical Director as the company enters its next phase of growth.

March 30, 2021
·
3 min read
Policy

PTC Therapeutics Announces the European Approval of Evrysdi™ for the Treatment of Spinal Muscular Atrophy

PTC Therapeutics, Inc. announced that the European Commission has granted marketing authorization to Evrysdi™ for the treatment of spinal muscular atrophy in patients 2 months and older.

March 30, 2021
·
9 min read
Deals

Breakthrough year in the development of Selvita - strategic acquisition & strong financial results

In 2020, Selvita recorded EUR 31.8 million in revenues, achieving an increase of 35% on a year on year (y/y) basis. Commercial revenues increased in 2020 to EUR 25.5 million, showing a 39% y/y increase

March 30, 2021
·
6 min read
Policy

Health Canada Provides Positive Feedback on Tetra Bio-Pharma’s Application for ARDS-003 to be Studied in COVID-19 Patients at Risk of Developing Acute Respiratory Distress Syndrome

Health Canada acknowledges that the preclinical safety data are robust and sufficient to file a Clinical Trial Application aimed at treating hospitalized COVID-19 patients at risk of developing ARDS

March 30, 2021
·
7 min read
Drug Development

InDex Pharmaceuticals enters agreement with Parexel Biotech for phase III clinical study of cobitolimod for ulcerative colitis

InDex Pharmaceuticals Holding AB announced that the company has entered an agreement for services with global clinical research organization Parexel Biotech for the phase III study CONCLUDE.

March 30, 2021
·
4 min read
Critical Limb Ischemia Treatment Market: Increase in Preference for Revascularization as Treatment Option to Drive Devices Segment

The global critical limb ischemia treatment market is driven by rise in prevalence of critical limb ischemia. Growth of the market is also attributed to increase in awareness about critical limb ischemia and rich product pipeline.

March 30, 2021
·
4 min read
Clinical Trial Management System Market: Software is anticipated to be Most Lucrative Segment

According to the report, the global clinical trials management system market was valued at US$ 1.4 Bn in 2018 and is anticipated to expand at a CAGR of 10.5% from 2019 to 2027

March 30, 2021
·
7 min read
ePharmacy Market: Rising Use of Mobile Apps for Prescription Refill is expected to boost growth of the Market

ePharmacy refers to an intermediate between seller and consumer for the purpose of selling of medicine. It is an online platform for the sale of medicines and is also widely known as mail order pharmacy and internet pharmacy.

March 30, 2021
·
4 min read
Interventional Radiology Market: Embolization to be Highly Lucrative Segment

According to the report, the global Interventional Radiology market was valued at US$ 16.4 Bn in 2018 and is anticipated to expand at a CAGR of 5.2% from 2019 to 2027

March 30, 2021
·
5 min read